Iran Psychiatric Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Department of Biochemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
Life Sci. 2020 Nov 1;260:118345. doi: 10.1016/j.lfs.2020.118345. Epub 2020 Aug 24.
High phenotypic and endophenotypic heritability of schizophrenia indicates substantial involvement of genetic elements in the occurrence of this disorder. Multiplicity of hypotheses about the genetic basis of schizophrenia pathogenesis suggests that there is still no integrated image from cellular and molecular infrastructure of this disorder.
Here, we aimed to gain an integrated insight into the genetic basis of schizophrenia through gene set enrichment and network analysis to find the most important developmental stages/brain regions, chromosomal locations and metabolic pathways involved in the pathogenesis of schizophrenia. We investigated major mental disorders whose genetic bases are significantly overlapping with the schizophrenia gene set.
Enrichment analyses uncovered 60 developmental stages/brain regions, 21 chromosomal hotspots and 16 pathways which are significantly associated with the found gene set. Our results demonstrated early mid-fetal/cortex as the most prominent developmental stage/brain region, chr16q22 as the most significant cytoband and the neuroactive ligand-receptor interaction as the most central pathway associated with schizophrenia. Further analyses revealed that autistic disorder has the most shared genes with schizophrenia. Moreover, mitogen-activated protein kinase-3 (MAPK3), calcium voltage-gated channel subunit alpha1 C (CACNA1C), solute carrier family 6 member 4 (SLC6A4) and 5-hydroxytryptamine receptor 2A (HTR2A) genes are the most central genes in the pathogenesis of schizophrenia.
In addition to summarizing what has been found on schizophrenia-associated genes in an integrative holistic framework, our results may help identify principle schizophrenia-associated cellular and molecular infrastructures, and provide support for further investigation on potential diagnostic and therapeutic biomarkers for schizophrenia.
精神分裂症的表型和内表型具有很高的遗传性,这表明遗传因素在这种疾病的发生中起了重要作用。关于精神分裂症发病机制的遗传基础的多重假说表明,目前仍然缺乏对这种疾病的细胞和分子结构的综合认识。
为了从基因集富集和网络分析的角度全面了解精神分裂症的遗传基础,以找到与精神分裂症发病机制相关的最重要的发育阶段/大脑区域、染色体位置和代谢途径,我们对遗传基础与精神分裂症基因集有显著重叠的主要精神障碍进行了研究。
富集分析发现了 60 个发育阶段/大脑区域、21 个染色体热点和 16 个与所发现的基因集显著相关的途径。我们的结果表明,从中孕期到胎儿大脑皮层是最突出的发育阶段/大脑区域,chr16q22 是最重要的染色带,神经活性配体-受体相互作用是与精神分裂症相关的最核心途径。进一步的分析表明,自闭症与精神分裂症的共享基因最多。此外,丝裂原活化蛋白激酶 3(MAPK3)、钙电压门控通道亚基α1 C(CACNA1C)、溶质载体家族 6 成员 4(SLC6A4)和 5-羟色胺受体 2A(HTR2A)基因是精神分裂症发病机制中最核心的基因。
除了以综合整体框架总结与精神分裂症相关基因的已有发现外,我们的结果可能有助于确定与精神分裂症相关的主要细胞和分子结构,并为进一步研究精神分裂症的潜在诊断和治疗生物标志物提供支持。